Nifty 50 has shown one of the strongest positive price seasonality. In the last 10 years, the index has closed in the green ...

On August 23, 2024, the FDA approved Amgen’s aflibercept biosimilar PAVBLU (aflibercept-ayyh), a biosimilar of Regeneron’s EYLEA®. According to the approval letter, “Pavblu is indicated for ...

Punjab National Bank: The state-run bank raised ₹ 5,000 crore via Qualified Institutions Placement (QIP). It allotted 48.19 ...

Bangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection ...

The inspection, which took place between September 23 and September 27, 2024, concluded with 4 observations from the ...

IDFC First Bank, PNB, Dr Reddy's, RIL, Biocon, and More - IDFC First Bank: The board has greenlighted the merger of IDFC Financial Holding Company with ...

Karnataka: Biocon Biologics has announced that the US Food and Drug Administration (USFDA) has completed a cGMP inspection at ...

Biocon shares fell 2% to Rs 361.5 after the USFDA issued four observations following an inspection of its Bengaluru API facility. The company will address these within the stipulated time and does not ...

Pharma company Biocon is set to announce its financial results for the quarter ended September 30, 2024, tomorrow, October 1 ...

Alembic Pharmaceuticals oral solid formulation facility (F-1) located in Panelav, Gujarat received establishment inspection report (EIR) from United States Food and Drug Administration (USFDA), which ...

Tata Motors has begun construction of a Rs 9,000-crore plant in Tamil Nadu for manufacturing Jaguar Land Rover vehicles.